Skip to content

Released Feb 25, 2026, after the close

10-K filed Feb 26, 2026, 57 days after period end · 0001653477-26-000014

Q4 2025 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$255.10Mderived+88.1% vs Q4 2024−23.4% vs Q3 2025
Net Income-$84.60MderivedN/M vs Q4 2024N/M vs Q3 2025
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$87,900,000−20.3%
Operating Cash Flowderived$97,100,000+50.5%
Free Cash Flowderived$73,500,000+85.6%
Margins · derived
Gross margin34.5%−46.9 pt vs Q4 2024
Net margin-33.2%−45.4 pt vs Q4 2024

What the release said

The release

Same quarter

MetricQ4 2025derived from reported figuresQ4 2024derived from reported figuresQ4 2023derived from reported figuresQ4 2022derived from reported figures
Revenue$255.10M$135.60M—$383.60M
Net Income-$84.60M$16.60M-$116.80M$15.60M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR